APSARD News & Updates
APSARD News & Updates contains content that addresses mental health practitioners, children and adults, ADHD and related disorders, and overall membership updates.
All APSARD members can submit their news and updates for posting. Submit your content to info@apsard.org for review and approval. Click the link below to reference a guide on how to write an article.
Please view and read the disclaimer before using News & Updates, by using News & Updates you agree to the terms and conditions.
➜ How to write an article
➜ Disclaimer
Featured Post
Stay in the Know with the latest APSARD News
Latest Posts
Medscape Features APSARD in the first US Adult ADHD Guidelines
The first ever U.S. clinical guidelines to diagnose and treat adult ADHD are expected to be released this fall. The guidelines are being developed by the American Professional Society of ADHD and Related Disorders (APSARD) due to a lack of existing standards and to...
What’s race got to do with it? Informant Rating Discrepancies in neuropsychological evaluations for children with ADHD
A recent study published in the National Institutes of Health's National Center for Biotechnology Information investigated racial bias in how children are diagnosed with ADHD. Researchers looked at data from nearly 4,000 children undergoing neuropsychological...
A Call to Action: Speak Up to End the Shortage of Stimulant Medication
Millions of Americans with Attention Deficit Hyperactivity Disorder (ADHD) rely on stimulant medications to manage their symptoms. However, the recent nationwide shortage has disrupted access to these essential drugs. The result has been devastating for so many...
New APSARD Strategic Plan!
VISION, MISSION, VALUESVISIONImproving the lives of people with ADHDMISSIONPromote interdisciplinary communication among researchers, clinicians, and educators to enhance the care for individuals living with ADHD throughout their lifespan. This is achieved by...
Treating Attention-Deficit/Hyperactivity Disorder Matters
A new JAMA study suggests ADHD medication may lower overall mortality risk. This large Swedish study followed nearly 150,000 ADHD patients. Those taking medication consistently saw a reduced risk of death from all and unnatural causes. Read the full article here:...
Addressing the Ongoing ADHD Medication Shortage: APSARD Member Featured in NBC News
The national shortage of ADHD medications, including Adderall, Ritalin, Focalin, and Vyvanse, continues to impact millions of individuals and their families. In response, a member of APSARD, was recently featured in an NBC News article discussing the challenges and...
Millions Face Challenges Obtaining ADHD Medication Due to Ongoing Shortage
The storm of the Adderall shortage hasn't subsided, leaving millions, including children with ADHD, facing continued difficulties obtaining their medication. This ongoing crisis, fueled by increased demand and manufacturing delays, forces families to scramble each...
APSARD 2024 Election Results
We are delighted to announce the results of our 2024 board elections, marking a significant transition in leadership. As we extend our appreciation to the outgoing board members, we are excited to welcome the newly elected individuals: Brooke Molina, PhD - President...
Late Breaking News From APSARD 2024 Conference
The Psychiatric Times has highlighted the 2024 APSARD Annual Conference in a featured article. This piece provides a concise overview of the sessions conducted by APSARD's Executive Committee Members on the first day, featuring presentations from experts such as Greg...